Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2014:2014:242703.
doi: 10.1155/2014/242703. Epub 2014 Aug 19.

Nicardipine-induced acute pulmonary edema: a rare but severe complication of tocolysis

Affiliations

Nicardipine-induced acute pulmonary edema: a rare but severe complication of tocolysis

Claire Serena et al. Case Rep Crit Care. 2014.

Abstract

We report four cases of acute pulmonary edema that occurred during treatment by intravenous tocolysis using nicardipine in pregnancy patients with no previous heart problems. Clinical severity justified hospitalization in intensive care unit (ICU) each time. Acute dyspnea has begun at an average of 63 hours after initiation of treatment. For all patients, the first diagnosis suspected was pulmonary embolism. The patients' condition improved rapidly with appropriate diuretic treatment and by modifying the tocolysis. The use of intravenous nicardipine is widely used for tocolysis in France even if its prescription does not have a marketing authorization. The pathophysiological mechanisms of this complication remain unclear. The main reported risk factors are spontaneous preterm labor, multiple pregnancy, concomitant obstetrical disease, association with beta-agonists, and fetal lung maturation corticotherapy. A better knowledge of this rare but serious adverse event should improve the management of patients. Nifedipine or atosiban, the efficiency of which tocolysis was also studied, could be an alternative.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Chest X-ray face-on in prone position (Case 2).
Figure 2
Figure 2
Chest X-ray face-on in prone position (Case 3).
Figure 3
Figure 3
Thoracic angioscan (Case 4).
Figure 4
Figure 4
Mode of action of calcium channel blockers.

Similar articles

Cited by

References

    1. Gáspár R, Hajagos-Tóth J. Calcium channel blockers as tocolytics: principles of their actions, adverse effects and therapeutic combinations. Pharmaceuticals. 2013;6(6):689–699. - PMC - PubMed
    1. Oei SG. Calcium channel blockers for tocolysis: a review of their role and safety following reports of serious adverse events. European Journal of Obstetrics Gynecology and Reproductive Biology. 2006;126(2):137–145. - PubMed
    1. Savitz DA, Blackmore CA, Thorp JM. Epidemiologic characteristics of preterm delivery: etiologic heterogeneity. American Journal of Obstetrics and Gynecology. 1991;164(2):467–471. - PubMed
    1. Clesham GJ, Scott J, Oakley CM, et al. β Adrenergic agonists and pulmonary oedema in preterm labour. British Medical Journal. 1994;308(6923):260–262. - PMC - PubMed
    1. Samet A, Bayoumeu F, Longrois D, Laxenaire MC. Acute pulmonary edema associated with the use of beta2-mimetic tocolytic agents. Annales Françaises d'Anesthésie et de Réanimation. 2000;19:35–38. - PubMed

LinkOut - more resources